Overview Fundamentals API Earnings EOD API Sample Code Pricing

Immunovant Inc (IMVT NASDAQ) stock market data APIs

$30.84 0.88(2.9%) as of November 12, 2024
Price chart is built with Anychart

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Immunovant Inc Financial Data Overview

29.96
30.84
-
31.18
29.85
24.67-45.58
4 571 M
147 M
0
-0.74
0.709
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'IMVT',
Type: 'Common Stock',
Name: 'Immunovant Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00P5MC0Q8',
ISIN: NULL,
CUSIP: NULL,
CIK: '1764013',
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: '2019-06-21',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic Primary',
IsDelisted: false,
}

Immunovant Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -352 164 992
  • Earnings Per Share -2.21
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Immunovant Inc Earnings via APIs

  • Latest Release 2024-11-07
  • EPS/Forecast -0.6

Get Immunovant Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com